The regenerative medicine service within Sanford Health's orthopaedics and sports medicine department, offering bone marrow and platelet injections at sites including Fargo.
This listing is a service line inside a large non-profit health system rather than a standalone cell therapy clinic. Sanford Health's regenerative medicine offering sits within its orthopaedics and sports medicine department, and the treatments are delivered at Sanford sites in Fargo, North Dakota and Sioux Falls, South Dakota. For a patient comparing providers, the practical significance is that this is hospital-based care with the oversight, records and referral pathways of a health system behind it, and with the option of conventional orthopaedic treatment in the same place if cell therapy is not appropriate.
Sanford Health defines regenerative medicine on its site as an area of medical care that uses cell therapy, such as stem cells or regenerative cells, to treat a disease or injury, and it describes itself as a leader in the field offering the most advanced regenerative medicine care in the region — a marketing claim a reader should note as such. The treatments described are orthobiologic injections, that is biological injections for bone, joint and tendon problems, using cells taken from the patient's own fat, blood or bone marrow. Bone marrow is described as drawn by aspiration from the pelvis. Alongside these the site lists platelet rich plasma (PRP, prepared from the patient's own blood), hyaluronic acid injections and corticosteroid injections to reduce inflammation.
All the material described is autologous (from the patient's own body): the page refers to cells from the patient's own fat, blood or bone marrow and names no donor, umbilical cord or amniotic product. The page does not, however, set out how the samples are processed, whether processing happens on site, or what the final injection is certified to contain — questions worth asking, even of a hospital programme.
The conditions named are narrower and more conservative than at most commercial clinics: arthritis, ligament injuries, and acute and chronic tendon injuries. Nothing on the page offers cell therapy for neurological, autoimmune or systemic disease. On cost, the programme is straightforward: it states that regenerative medicine therapies are not covered by most health insurers, and adds that the treatments may cost less than most insurance deductibles — though no figure is given, so a prospective patient should ask for one.
The conditions listed are musculoskeletal and relatively narrow compared with commercial cell therapy clinics.
The site states that its orthobiologic treatments use cells taken from the patient's own fat, blood or bone marrow, with bone marrow drawn by aspiration from the pelvis.
No individual physician is named on the regenerative medicine page reviewed; the service is presented as part of the health system's orthopaedics and sports medicine department, and a prospective patient would need to ask which clinician they would see at their chosen site.
The service is delivered within Sanford Health, a large non-profit health system, at its orthopaedics and sports medicine sites in Fargo, North Dakota and Sioux Falls, South Dakota, each with its own contact number given on the page. Because this is hospital-based care, the setting includes the imaging, laboratory and specialist referral infrastructure of the wider system, and a patient who is not a candidate for injection treatment can be directed to conventional orthopaedic options within the same department. The page does not describe a dedicated cell-processing laboratory or state any specific accreditation for the regenerative service, and it does not mention languages, though a health system of this size would normally be able to arrange interpreting on request.
The site does not give a figure, but it is clear about the funding position: it states that regenerative medicine therapies are not covered by most health insurance providers, and that the treatments may cost less than most insurance deductibles. In practice that means patients should expect to pay privately. A prospective patient should ask for a written price for the specific injection proposed, and should not rely on the deductible comparison, which is a general statement rather than a quotation.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.